Dear Colleagues and Friends:
We are pleased to announce that the Symposium on Advanced Delivery Materials for Innovative Therapy (ADMIT 2026) will be held in October 16-18, 2026 at the Worldhotel Grand DushuLake, Suzhou, China.
ADMIT, formerly known as SIPCD, has been held biennially since its inception in 2010 and has evolved into a highly regarded international academic conference in the fields of biomedical materials, controlled release technology, and pharmaceutical sciences. The conference was renamed ADMIT to better align with the cutting-edge developments in biomedicine and drug delivery. ADMIT aims to provide a unique and open platform for scientific exchange—one that not only showcases the latest advances in drug delivery technologies and research findings but also encourages open and insightful discussion on critical challenges and potential solutions, thereby laying a foundation for future progress and clinical translation.
ADMIT 2026 has following highlights:
● 400 Participants in one single session ● 27 Plenary lectures given by worldwide top scientists
● A rising star session (15 short lectures) ● 10 Best Poster Awards presented by JCR
● Vivid social program for networking ● Celebration of the 80th birthday of Prof. Jan Feijen
● Publication of a special issue in JCR
B
